For the most part, biotech stocks have taken a beating this year, along with the broader market. The Nasdaq Biotechnology Index (INDEXNASDAQ: NBI) is down over 26% this year, while the S&P 500 is ...
For the most part, biotech stocks have taken a beating this year, along with the broader market. The Nasdaq Biotechnology Index (INDEXNASDAQ: NBI) is down over 26% this year, while the S&P 500 is ...